98 related articles for article (PubMed ID: 24945225)
1. Hyperglycemia and hepatic tumors in ICR mice neonatally injected with streptozotocin.
Ariza L; Zaguirre M; García M; Blasco E; Rabanal RM; Bosch A; Otaegui PJ
Lab Anim (NY); 2014 Jul; 43(7):242-9. PubMed ID: 24945225
[TBL] [Abstract][Full Text] [Related]
2. Recovery from diabetes in neonatal mice after a low-dose streptozotocin treatment.
Kataoka M; Kawamuro Y; Shiraki N; Miki R; Sakano D; Yoshida T; Yasukawa T; Kume K; Kume S
Biochem Biophys Res Commun; 2013 Jan; 430(3):1103-8. PubMed ID: 23257160
[TBL] [Abstract][Full Text] [Related]
3. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
4. Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice.
Ventura-Sobrevilla J; Boone-Villa VD; Aguilar CN; Román-Ramos R; Vega-Avila E; Campos-Sepúlveda E; Alarcón-Aguilar F
Proc West Pharmacol Soc; 2011; 54():5-9. PubMed ID: 22423571
[TBL] [Abstract][Full Text] [Related]
5. Impact of maternal mild hyperglycemia on maternal care and offspring development and behavior of Wistar rats.
Kiss AC; Woodside B; Felício LF; Anselmo-Franci J; Damasceno DC
Physiol Behav; 2012 Oct; 107(3):292-300. PubMed ID: 22892541
[TBL] [Abstract][Full Text] [Related]
6. Effect of Sanguis draconis (a dragon's blood resin) on streptozotocin- and cytokine-induced β-cell damage, in vitro and in vivo.
Hu CM; Li JS; Cheah KP; Lin CW; Yu WY; Chang ML; Yeh GC; Chen SH; Cheng HW; Choy CS
Diabetes Res Clin Pract; 2011 Dec; 94(3):417-25. PubMed ID: 21899910
[TBL] [Abstract][Full Text] [Related]
7. A new animal model of non-insulin-dependent diabetes mellitus with hypertension: neonatal streptozotocin treatment in spontaneously hypertensive rats.
Iwase M
Fukuoka Igaku Zasshi; 1991 Jul; 82(7):415-27. PubMed ID: 1833297
[TBL] [Abstract][Full Text] [Related]
8. Comparison of single high-dose streptozotocin with partial pancreatectomy combined with low-dose streptozotocin for diabetes induction in rhesus monkeys.
Jin X; Zeng L; He S; Chen Y; Tian B; Mai G; Yang G; Wei L; Zhang Y; Li H; Wang L; Qiao C; Cheng J; Lu Y
Exp Biol Med (Maywood); 2010 Jul; 235(7):877-85. PubMed ID: 20558842
[TBL] [Abstract][Full Text] [Related]
9. The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.
Noh JR; Hwang JH; Kim YH; Kim KS; Gang GT; Kim SW; Kim DK; Shong M; Lee IK; Choi HS; Lee CH
Int J Biochem Cell Biol; 2013 Aug; 45(8):1538-45. PubMed ID: 23680671
[TBL] [Abstract][Full Text] [Related]
10. Strain differences in the diabetogenic activity of streptozotocin in mice.
Hayashi K; Kojima R; Ito M
Biol Pharm Bull; 2006 Jun; 29(6):1110-9. PubMed ID: 16755002
[TBL] [Abstract][Full Text] [Related]
11. Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice.
Kojima S; Asakawa A; Amitani H; Sakoguchi T; Ueno N; Inui A; Kalra SP
Peptides; 2009 May; 30(5):962-6. PubMed ID: 19428774
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of bezafibrate on streptozotocin-induced oxidative stress and toxicity in rats.
Anwer T; Sharma M; Pillai KK; Haque SE; Alam MM; Zaman MS
Toxicology; 2007 Jan; 229(1-2):165-72. PubMed ID: 17145126
[TBL] [Abstract][Full Text] [Related]
13. Studies on sex dependency of B-cell susceptibility to streptozotocin in a rat model of type II diabetes mellitus.
Ostenson CG; Grill V; Roos M
Exp Clin Endocrinol; 1989 May; 93(2-3):241-7. PubMed ID: 2528471
[TBL] [Abstract][Full Text] [Related]
14. Glucose transporter 2 expression: prevention of streptozotocin-induced reduction in beta-cells with 5-thio-D-glucose.
Wang Z; Gleichmann H
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():83-97. PubMed ID: 8839260
[TBL] [Abstract][Full Text] [Related]
15. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin.
Hosokawa M; Dolci W; Thorens B
Biochem Biophys Res Commun; 2001 Dec; 289(5):1114-7. PubMed ID: 11741307
[TBL] [Abstract][Full Text] [Related]
17. Insights into modeling streptozotocin-induced diabetes in ICR mice.
Dekel Y; Glucksam Y; Elron-Gross I; Margalit R
Lab Anim (NY); 2009 Feb; 38(2):55-60. PubMed ID: 19165193
[TBL] [Abstract][Full Text] [Related]
18. Streptozotocin dose-response curve in tilapia, a glucose-responsive teleost fish.
Wright JR; Abraham C; Dickson BC; Yang H; Morrison CM
Gen Comp Endocrinol; 1999 Jun; 114(3):431-40. PubMed ID: 10336831
[TBL] [Abstract][Full Text] [Related]
19. Streptozotocin is equally diabetogenic whether administered to fed or fasted mice.
Chaudhry ZZ; Morris DL; Moss DR; Sims EK; Chiong Y; Kono T; Evans-Molina C
Lab Anim; 2013 Oct; 47(4):257-65. PubMed ID: 23760565
[TBL] [Abstract][Full Text] [Related]
20. Influence of postnatal overnutrition and pregnancy on non-insulin dependent diabetes induced in Wistar rats by neonatal streptozotocin.
Mende S; Mühle W; Peters WH
Horm Metab Res; 1996 Feb; 28(2):81-5. PubMed ID: 8867903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
